Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-020-03471-9
Abstract: Introduction Positive cytology from peritoneal washings obtained prior to potential resection of pancreatic cancer is associated with grim prognosis, equivalent to M1 disease. We examine our experience with pancreatic cancer patients who underwent pre-resection lavage… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.03.031
Abstract: BACKGROUND To examine the association between malignant peritoneal cytology and survival in women with early-stage endometrioid endometrial cancer. METHODS This is a retrospective cohort study using the Surveillance, Epidemiology, and End Results Program from 2010… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2105208
Abstract: ABSTRACT Introduction In endometrial cancer, malignant peritoneal cytology (MPC) refers to the presence of tumor cells in the peritoneal cytologic specimen obtained at hysterectomy. MPC was once a component of uterine cancer staging criteria, but… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Histopathology"
DOI: 10.1111/his.14092
Abstract: The peritoneal regression grading score (PRGS) and peritoneal cytology (PC) assess response to chemotherapy in peritoneal metastasis (PM) in a setting of palliative treatment by pressurized intraperitoneal aerosol chemotherapy (PIPAC). Progression has been defined as… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15457
Abstract: This study aims to examine the association between malignant peritoneal cytology and prognosis in women with endometrial cancer. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-esgo.582
Abstract: Introduction/Background Although peritoneal cytology in endometrial carcinoma was excluded from the staging system (FIGO 2008), the management for patients with positive peritoneal cytology remains controversial. The aim of this study is to evaluate the clinical… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Computational and Mathematical Methods in Medicine"
DOI: 10.1155/2022/1906769
Abstract: Endometrial carcinoma (EC) is one of the most common gynecological malignancies. Its incidence rate has been increasing year by year. The prognostic factors and treatment strategies of EC have aroused wide concern. The effects of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.110
Abstract: 110 Background: We previously reported that the superiority of neoadjuvant chemotherapy (NAC) with S-1 plus cisplatin was not demonstrated for schirrhous or similar macroscopic type (type 4 or large type 3) gastric cancer. However, overall… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-021-09900-4
Abstract: The aim of this study was to examine the survival effect of adjuvant therapy in stage II–III endometrial cancer based on peritoneal cytology results. The National Cancer Institute’s Surveillance, Epidemiology, and End Results Program was… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Cytology"
DOI: 10.4103/joc.joc_53_22
Abstract: Purpose: It is still debatable whether surgical staging of endometrial cancer (EC) should include sampling of peritoneal cytology (PC) and for what purpose this should be done. The aim of our study was to determine… read more here.